Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Certara Inc (NQ: CERT ) 13.29 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Certara Inc < Previous 1 2 Next > Certara to Participate in Upcoming Investor Conferences August 21, 2024 From Certara Via GlobeNewswire Certara Launches Phoenix™ Version 8.5 Drug Development Software August 15, 2024 From Certara Via GlobeNewswire Certara Reports Second Quarter 2024 Financial Results August 06, 2024 Reiterates Full Year 2024 Financial Guidance From Certara Via GlobeNewswire Certara to Acquire Chemaxon to Strengthen Drug Discovery Software Portfolio July 09, 2024 From Certara Via GlobeNewswire Simulations Plus Stock Drops 15% Despite EPS Beat July 05, 2024 Simulations Plus fell 15% the day after its earnings release despite beating EPS estimates due to lower margins and lower full-year guidance. Via MarketBeat Topics Artificial Intelligence Exposures Artificial Intelligence Certara to Report Second Quarter 2024 Financial Results on August 6th, 2024 July 02, 2024 From Certara Via GlobeNewswire Certara Launches Next Generation CoAuthor™ Generative AI Regulatory Writing Software June 17, 2024 AI-enabled solutions accelerate regulatory and medical writing processes, enhancing quality, transparency, and efficiencies From Certara Via GlobeNewswire Certara to Participate in the Jefferies Global Healthcare Conference May 29, 2024 From Certara Via GlobeNewswire Certara Appoints New Chief Human Resources Officer & General Counsel May 21, 2024 From Certara Via GlobeNewswire Certara Reports First Quarter 2024 Financial Results May 07, 2024 Reiterates Full Year 2024 Financial Guidance From Certara Via GlobeNewswire Certara Launches Cloud Platform to Further Unify its End-to-End Scientific Software Platform April 16, 2024 From Certara Via GlobeNewswire Certara to Report First Quarter 2024 Financial Results on May 7th, 2024 and Participate in the BofA Securities Healthcare Conference April 09, 2024 From Certara Via GlobeNewswire Certara Reports Fourth Quarter 2023 Financial Results February 29, 2024 Provides Full Year 2024 Financial Guidance From Certara Via GlobeNewswire Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference February 01, 2024 From Certara Via GlobeNewswire Certara Acquires Applied BioMath Expanding Its Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing for Novel Therapies December 13, 2023 Combined organization establishes the life sciences industry’s largest quantitative systems pharmacology (QSP) center of excellence contributing to faster and more effective medicine development. From Certara Via GlobeNewswire Certara introduces Simcyp™ Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development November 21, 2023 Simcyp Biopharmaceutics helps drug developers replace costly clinical bioequivalence studies and optimize formulations for complex therapies From Certara Via GlobeNewswire Certara Reports Third Quarter 2023 Financial Results November 08, 2023 Reiterates Full Year 2023 Financial Guidance From Certara Via GlobeNewswire Certara to Report Third Quarter 2023 Financial Results on November 8th, 2023, and participate in the Stephens Annual Investment Conference October 11, 2023 From Certara Via GlobeNewswire Certara Announces 300th Regulatory Submission Milestone Using its Technology-enabled Services and Software September 19, 2023 Dedicated team of global regulatory experts delivers submissions in increasingly shorter timelines From Certara Via GlobeNewswire Certara to Participate in Upcoming Investor Conferences August 29, 2023 From Certara Via GlobeNewswire Certara Simcyp™ Group Awarded Two New Grants from US FDA August 29, 2023 Programs focus on use of physiologically-based pharmacokinetic (PBPK) modeling for demonstrating virtual bioequivalence and predicting drug absorption of topical formulations From Certara Via GlobeNewswire Certara Reports Second Quarter 2023 Financial Results August 09, 2023 Provides Update to Full Year 2023 Financial Guidance From Certara Via GlobeNewswire Certara to Report Second Quarter 2023 Financial Results on August 9th, 2023 July 13, 2023 From Certara Via GlobeNewswire Certara to Participate in the Jefferies Global Healthcare Conference June 02, 2023 From Certara Via GlobeNewswire Certara Reports First Quarter 2023 Financial Results May 08, 2023 Reiterates 2023 Financial Guidance From Certara Via GlobeNewswire Certara Customers Received 90 Percent of US FDA Novel Drug Approvals for 9th Consecutive Year April 27, 2023 Asserts Certara’s leadership in advancing the development and approval of new drugs for patients From Certara Via GlobeNewswire Certara to Report First Quarter 2023 Financial Results on May 8th, 2023 and Participate in the BofA Securities 2023 Healthcare Conference April 10, 2023 From Certara Via GlobeNewswire Are These 3 Small Momentum Stocks Setting Up Big Gains? March 22, 2023 MINISO, PDF Solutions, and Certara are small stocks with strong price momentum. It’s not unusual for small stocks to show more price momentum than larger peers. Via MarketBeat A.I. Coming to Certara’s D360 Scientific Informatics Software March 09, 2023 New deep learning capabilities will provide data and insight to inform property prioritization, novel structure design and literature-based analyses. From Certara Via GlobeNewswire Certara announces the release of Simcyp™ PBPK Simulator Version 22, expanding ability to simulate untested scenarios for new patient and therapeutic types March 07, 2023 Simcyp Simulator has been utilized to inform more than 300 label claims for 90+ novel drugs in lieu of conducting clinical studies From Certara Via GlobeNewswire < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.